News

A Natural Path to Cognitive Enhancement with Somin-On™ Ashwagandha

A Natural Path to Cognitive Enhancement with Somin-On™ Ashwagandha

Enhancing Memory and Cognitive Function with Somin-On™ Ashwagandha

Arjuna Natural introduces its innovative ashwagandha ingredient, designed to help maintain brain function in mature adults enduring mild cognitive challenges.

Understanding Somin-On™

Somin-On™ is the newest addition to Arjuna Natural's esteemed range of botanical formulations. What sets this particular ashwagandha product apart is its specific standardization to a 2% Sominone content, confirmed through HPLC. This formulation aims to enhance cognitive functions, specifically targeting attention and memory retention for individuals facing mild cognitive impairment (MCI).

Plant-Powered Cognitive Support

Benny Antony, PhD, Joint Managing Director of Arjuna Natural, emphasized the relevance of this new formulation, stating, "Our ashwagandha formula responds to the pressing concerns surrounding cognitive decline in the aging population. Many are searching for natural solutions to uphold mental clarity and stave off potential dementia as they grow older. Somin-On provides a promising, safe, and natural approach towards maintaining cognitive function and overall mental agility in older adults."

Mild cognitive impairment, while not severe enough to interrupt daily life, can alter memory and cognition noticeably. Research indicates that around 16% of individuals over 70 may experience some form of MCI. Alarmingly, studies show that nearly 50% of those diagnosed with MCI may develop Alzheimer's disease within five years, marking MCI as an early warning sign of potential dementia.

Addressing an Unmet Need

Dr. Antony highlighted the lack of approved treatments for MCI, stating, "Somin-On is our solution to bridge this gap and combat cognitive decline through natural means." This commitment to cognitive health has pushed Arjuna Natural to explore the potential benefits of Somin-On.

Conducted at the Hi-Tech Hospital and Trauma Center in Uttar Pradesh, India, a pivotal double-blind, placebo-controlled study led by Dr. Hari Prakash Rai enlisted 40 adults diagnosed with MCI. The participants were split into two groups: one receiving a daily dose of 250mg of Somin-On and the other a placebo, monitored over 60 days with evaluations at 30 and 60 days intervals.

Results from the Study

The findings were promising, indicating significant advancements across various cognitive function metrics in those consuming Somin-On versus those on placebo. Subjects reported improvements in immediate memory, general memory, and working memory according to the Wechsler Memory Scale-III (WMS-III). The Somin-On group also demonstrated significant enhancements in visuospatial processing from day 30 to day 60, as indicated by the Shepard Mental Rotation Test scores.

Further evaluations, including the Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE), indicated noteworthy improvements in memory functions, including word recall, arithmetic abilities, language comprehension, and even basic motor skills. These results underscore Somin-On's potential role in augmenting attention, expediting information processing, and elevating overall cognitive prowess while reducing cognitive impairments.

The Science Behind Sominone

According to Dr. Antony, Sominone, derived from the Withania somnifera plant, is identified as the primary active component driving these benefits. Historically recognized as a notable Ayurvedic herb, ashwagandha has been utilized for centuries to mitigate stress and anxiety while promoting cognitive support. Sominone is recognized for its capability to enhance memory and cognitive functionalities.

Research demonstrates that Sominone can repair and rejuvenate nerve cells affected by amyloid-beta, a protein known to compromise brain connections. In animal studies, it has shown promise in enhancing neurite outgrowth and improving spatial memory, alongside bolstering nerve cell growth and repair, ultimately fostering cognitive enhancement.

In addition, this ashwagandha extract counteracts oxidative stress and mitochondrial dysfunction, showcasing its neuroprotective and anti-degenerative characteristics. Somin-On is presented as a sequel to Arjuna's acclaimed ashwagandha product, Shoden, which is standardized to 35% withanolide glycosides and supported by numerous clinical investigations aimed at alleviating stress, improving sleep quality, and overcoming anxiety.

About Arjuna Natural

Having established itself as a leader in India for over 25 years, Arjuna Natural specializes in standardized spice and botanical extracts for the food supplement industry. Founded in 1989, the company prioritizes eco-friendly and sustainable practices and serves clients across 70 nations. Its advanced research facility collaborates with international universities to innovate in phytochemistry, pharmacokinetics, formulation, and pre-clinical research. Arjuna's facilities meet the highest global standards for GMP certification while also obtaining ISO, NSF, Star-K kosher, and halal certifications.

Contact Information

For more details, reach out to Arjuna Natural Pvt. Ltd.
Benny Antony, PhD
Joint Managing Director

Website: www.arjunanatural.com
Twitter: @ArjunaExtracts

Frequently Asked Questions

What is Somin-On™ Ashwagandha?

Somin-On™ is an advanced ashwagandha extract formulated to enhance cognitive functions such as memory and attention.

Who can benefit from Somin-On™?

This product is aimed at adults experiencing mild cognitive impairment wishing to maintain better memory and cognitive function.

How does Somin-On™ work?

Somin-On™ contains Sominone, an active component that enhances nerve repair and supports cognitive function through its neuroprotective properties.

What does the clinical study reveal?

The clinical trial demonstrated significant improvements in memory, cognitive performance, and overall brain function among participants using Somin-On™.

What makes Arjuna Natural a trusted name?

Arjuna Natural has over 25 years in the industry, renowned for eco-friendly practices and high-quality botanical extracts, certified at global standards.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

IDX Expands, Enhances Team Amid 56% H1 Growth

Updated Category News Views 1

IDX's Aggressive Global Expansion Here's a tip from a trader who’s seen cycles rise and fall: watch the movers who're playing the long game, putting down roots worldwide while making headway in the data game. IDX has clearly mapped out this trajectory as evidenced by its recent grab in the global strategic communications ring. IDX's bustling around like a squirrel...

Continue Reading
BrightPlan's AI-Powered Growth: Series C Fuel

Updated Category News Views 5

Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...

Continue Reading
The Austin Company to Showcase at ISPE Annual Event

Updated Category News Views 2

Setting the Stage at ISPE Expo When you think of pharmaceuticals and the bustle behind closed doors, it's with companies like The Austin Company leading the charge. This October, they're strutting their stuff at the ISPE Annual Meeting and Expo. No small potatoes here—it's at the Gaylord National in Maryland. Mark those dates: October 18-21, 2026. It's a circus of...

Continue Reading
Verdafero Gains Ground in Sustainable Hospitality

Updated Category News Views 3

Verdafero's Latest Milestone: A Broader Environmental Reach It’s a day like today that makes you pause and realize that businesses in the hospitality space aren’t just about fluff and fancy lobbies anymore. They've got a new wave of responsibilities, especially with the globe pretty much on fire, literally and figuratively. Verdafero, a name not new to function and...

Continue Reading
ASCEND® Cladding Unveils New Profiles & Texture Variety

Updated Category News Views 1

New Options for Creative Home Exteriors Amid today's housing market rollercoaster, a sprinkle of bold innovation in building materials can make a statement—and that's precisely what Associated Materials Innovations (AMI) is banking on with their latest beef-up in the ASCEND® Composite Cladding lineup. Introduced out of Cuyahoga Falls on Sept. 8, 2026, this expansion...

Continue Reading
Everpure Surges into the S&P 500: A Milestone Move

Updated Category News Views 10

Big Leagues Beckon: Everpure Enters the S&P 500 Another day, another dollar, but today ain't just any day for Everpure. They’re stepping up from the minor leagues and grabbing their spot in the illustrious S&P 500 lineup. We're talking about a milestone that every company dreams of, but few achieve—this ain't your regular Tuesday headline. Stock Market's Stamp of...

Continue Reading
Big Wins at Americas Cardroom's $15M Venom Series

Updated Category News Views 3

High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...

Continue Reading
Stoke Space Raises $1B; XTEND AI Hits NYSE

Updated Category News Views 3

A Billion-Dollar Boost for Stoke Space Ever catch wind of a company hauling in a cool billion and shrug it off? Me neither. Stoke Space Technologies just locked down $1 billion in Series E funding. This ain't some pocket change—the kind of dough you need when you're eyeing stars and plotting orbital voyages. They're gearing up for a 2027 mission with their Nova...

Continue Reading
Jollibee and DreamWorks Unite for Cultural Celebration

Updated Category News Views 4

Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...

Continue Reading
AllyGPO Shines as Top Innovator in Health Tech

Updated Category News Views 3

Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Viridien S.A. Announces Senior Secured Notes Launch Strategy

Updated Category News Views 197

Viridien S.A. Launches Senior Secured Notes Offering Viridien S.A., the parent company of the Viridien group, has initiated a significant offering of senior secured notes. This offering includes notes due in 2030, available in both U.S. dollars and euros, amounting to an impressive total of approximately US$950,000,000. The newly issued notes will be backed by guarantees...

Continue Reading
China's Strategic Shift: Boosting Domestic Chip Production

Updated Category News Views 286

China's Bold Move to Support Data Centers China has recently implemented significant subsidies aimed at reducing energy costs for major data centers, achieving cuts of up to 50%. This initiative seeks to enhance the competitiveness of domestic chipmakers while addressing rising operational expenses. High Energy Costs for Tech Giants In provinces well-known for their data...

Continue Reading
Lexibook Reports Strong Q3 Growth with €39.3M Revenue Surge

Updated Category News Views 269

Lexibook's Impressive Q3 Performance Lexibook has reported a remarkable financial performance for the third quarter of the 2024-25 fiscal year, achieving a revenue of €39.3 million. This marks a significant increase of 31.1%, rising from €30 million in the same quarter of the previous year. This impressive growth reaffirms the company’s strategies and its focus on...

Continue Reading
Gray Media Boosts Offering with $775 Million First Lien Notes

Updated Category News Views 232

Gray Media Enhances Financial Strategy with $775 Million Notes ATLANTA – Gray Media, Inc. (“Gray”) (NYSE: GTN) has announced a significant enhancement to its financial position by pricing a private offering of $775 million aggregate principal amount of 7.250% senior secured first lien notes due 2033. This announcement marks an increase of $75 million over the...

Continue Reading
GENDA Inc. Expands Its Amusement Portfolio with Acquisition

Updated Category News Views 290

GENDA Inc. Acquires Player One Amusement Group GENDA Inc. has officially expanded its reach in the entertainment industry by acquiring Player One Amusement Group. This strategic acquisition is expected to significantly enhance GENDA's operations, allowing it to offer a more varied entertainment experience to its customers. Expanding Geographic Reach The integration of...

Continue Reading